Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.

Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.

Item
http://www.wikidata.org/entity/Q44600048
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsNovel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwideThe Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial FibrillationCost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial FibrillationDabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stayPotential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care.Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review.A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
P2860

Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.

Item
http://www.wikidata.org/entity/Q44600048
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@en
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@nl
type
label
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@en
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@nl
prefLabel
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@en
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Cost-effectiveness of dabigatr ...... atrial fibrillation in Sweden.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698